Standard and low-dose IGF-I generation tests and spontaneous growth hormone secretion in children with idiopathic short stature

被引:46
作者
Blair, JC
Camacho-Hübner, C
Moud, FM
Rosberg, S
Burren, C
Lim, S
Clayton, PE
Bjarnason, R
Albertsson-Wikland, K
Savage, MO
机构
[1] St Bartholomews & Royal London Sch Med & Dent, Dept Endocrinol, Paediat Endocrinol Sect, London, England
[2] Int Growth Res Ctr, Gothenburg, Sweden
[3] Royal Manchester Childrens Hosp, Manchester M27 1HA, Lancs, England
关键词
D O I
10.1046/j.1365-2265.2004.01957.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Abnormalities in the GH-IGF-I axis, consistent with GH insensitivity (GHI), have been reported in some patients with idiopathic short stature (ISS). The standard IGF-I generation test (IGFGT) has not demonstrated mild GHI in subjects with ISS. The aim of this study was to investigate the GH-IGF-I axis in ISS by performing standard and novel low-dose IGFGTs together with determination of spontaneous GH secretion. PATIENTS AND METHODS Twenty-one (17 male) prepubertal children with ISS, mean age 8.3 years (4.5-12.2), mean height -3.48 SD (-5.40 to -1.79), mean peak GH to provocation with glucagon/clonidine 32.3 mU/l (14.1-66.0) were studied. Serum IGF-I and IGFBP-3 levels were measured during standard (GH 0.033 mg/kg/day x 4) and low (GH 0.011 mg/kg/day x 4) dose IGFGTs at 0, 12, 36 and 84 h. The low-dose IGFGT was performed in seven naive GH-deficient patients (4 male), mean age 8.5 years (range 4.1-11.1). Determination of spontaneous 24-h GH secretion was performed in the 21 ISS patients. RESULTS Basal IGF-I and IGFBP-3 standard deviation scores (SDS) in ISS patients were -1.39 (-2.4-1.16) and -0.45 (-1.13-0.38), respectively, IGF-I being lower than IGFBP-3 (P < 0.0001). IGF-I increased in the standard IGFGT at 12 h (P < 0.005), 36 h (P < 0.001) and 84 h (P < 0.001); maximal increment 1.54 (-0.32-3.48), and in the low-dose test at 12 h (P < 0.005), 36 h (P < 0.001) and 84 h (P < 0.005); maximal increment 0.53 (0.08 to -1.23). IGFBP-3 SDS increased in the standard IGFGT at 36 h (P < 0.01) and 84 h (P < 0.001); maximal increment 0.72 (-0.44-1.96), and in the low-dose test at 84 h (P < 0.005); maximal increment 0.33 (-0.08-0.87). Five/19 patients with an IGF-I response > 2 x coefficient of variation (CV) of assay in the standard test failed to respond in the low-dose test, suggestive of mild GHI. In GH-deficient patients, IGF-I increased at each time point (P < 0.05) and IGFBP-3 at 36 h (P < 0.05). Mean GH secretion, expressed in SDS, compared with 66 normal stature controls was: basal GH -0.48 (-0.84-0.93), height of GH peaks compared with zero -0.36 (-1.26-1.51) (both P < 0.05), total GH secretion -0.76 (-1.22-0.42), total GH secretion above baseline -0.67 (-1.21-0.94) (both P < 0.01). CONCLUSIONS In children with ISS, basal IGF-I and IGFBP-3 SDS values were below the mean, IGF-I showing a greater response in both IGFGTs. In the standard IGFGT, the IGF-I increase at 36 h was equal to that at 84 h. The low-dose IGFGT, in combination with the standard test, may identify patients with mild GHI.
引用
收藏
页码:163 / 168
页数:6
相关论文
共 33 条
[1]   ANALYSIS OF 24-HOUR GROWTH-HORMONE PROFILES IN HEALTHY BOYS AND GIRLS OF NORMAL STATURE - RELATION TO PUBERTY [J].
ALBERTSSONWIKLAND, K ;
ROSBERG, S ;
KARLBERG, J ;
GROTH, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (05) :1195-1201
[2]   EVIDENCE FOR PARTIAL GROWTH-HORMONE INSENSITIVITY AMONG PATIENTS WITH IDIOPATHIC SHORT STATURE [J].
ATTIE, KM ;
CARLSSON, LMS ;
RUNDLE, AC ;
SHERMAN, BM .
JOURNAL OF PEDIATRICS, 1995, 127 (02) :244-250
[3]   A dominant-negative mutation of the growth hormone receptor causes familial short stature [J].
Ayling, RM ;
Ross, R ;
Towner, P ;
VonLaue, S ;
Finidori, J ;
Moutoussamy, S ;
Buchanan, CR ;
Clayton, PE ;
Norman, MR .
NATURE GENETICS, 1997, 16 (01) :13-14
[4]   Spontaneous growth hormone secretory characteristics in children with partial growth hormone insensitivity [J].
Bjarnason, R ;
Banerjee, K ;
Rose, SJ ;
Rosberg, S ;
Metherell, L ;
Clark, AJL ;
Albertsson-Wikland, K ;
Savage, MO .
CLINICAL ENDOCRINOLOGY, 2002, 57 (03) :357-361
[5]   The GH-IGF-I axis in children with idiopathic short stature [J].
Blair, JC ;
Savage, MO .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2002, 13 (08) :325-330
[6]   IMPROVEMENT OF DIAGNOSTIC-CRITERIA IN GROWTH-HORMONE INSENSITIVITY SYNDROME - SOLUTIONS AND PITFALLS [J].
BLUM, WF ;
COTTERILL, AM ;
POSTELVINAY, MC ;
RANKE, MB ;
SAVAGE, MO ;
WILTON, P ;
BOULTON, J ;
BRAMSWIG, J ;
CARUSO, M ;
CHATELAIN, P ;
CHAUSSAIN, J ;
DESPERT, F ;
FRASER, N ;
FRISCH, H ;
HEINRICH, C ;
HEINRICH, U ;
HERREREAJUSTINIANO, E ;
HOPP, M ;
KASTRUP, K ;
KRIZISNIK, C ;
LOCHE, S ;
MILNER, D ;
PINTOR, C ;
PRICE, A ;
RANKE, M ;
RAPPAPORT, R ;
ROCHICCIOLI, P ;
DESANCTIS, C ;
SAVAGE, M ;
SKAKKEBAEK, N ;
TRAUBER, M ;
WERTHER, G ;
YOULTON, R .
ACTA PAEDIATRICA, 1994, 83 :117-124
[7]   Insulin-like growth factor binding protein-3 generation as a measure of GH sensitivity [J].
Buckway, CK ;
Selva, KA ;
Pratt, KL ;
Tjoeng, E ;
Guevara-Aguirre, J ;
Rosenfeld, RG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (10) :4754-4765
[8]   The IGF-I generation test revisited: A marker of GH sensitivity [J].
Buckway, CK ;
Guevara-Aguirre, J ;
Pratt, KL ;
Burren, CP ;
Rosenfeld, RG .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) :5176-5183
[9]  
Cameron N., 1978, HUMAN GROWTH, DOI [10.1007/978-1-4684-2622-9_3, DOI 10.1007/978-1-4684-2622-9_3]
[10]  
CARLSSON LMS, 1996, GROWTH HORMONE RESIS, P389